Cancer specialist, Reframe Cancer, has appointed Professor Ben Kelly as its chief operating officer.
Kelly joins the firm from Nuffield Health, where he held senior leadership positions for over ten years. Reframe Cancer highlighted Kelly's data and evidence first approaches whilst at Nuffield Health as key reasons for his appointment. Mark Stephenson, CEO, Reframe Cancer, said: "We're naturally thrilled that Professor Ben Kelly has joined Reframe Cancer as Chief Operating Officer. "His experience and clinical data expertise will facilitate Reframe Cancer in supporting even more patients as well as delivering industry leading outcomes." Earlier this year, Reframe Cancer partne...
To continue reading this article...
Join COVER for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.
